Navigation Links
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
Date:4/17/2008

e treatments, and provide a more-informed prognosis for patients and their families.

About ALTROPANE Imaging Agent and Parkinsonian Syndromes Including Parkinson's Disease

ALTROPANE is a molecular imaging agent that specifically binds to the dopamine transporter (DAT) protein found on the surface of dopamine-producing neurons, making it visible during Single Photon Emission Computed Tomography or "SPECT" imaging. Since most forms of Parkinsonian Syndromes result in a decreased number of dopamine-producing cells, it would be expected that these patients also have fewer DATs than do patients without Parkinsonian Syndromes. ALTROPANE used in conjunction with SPECT imaging could be a useful test to distinguish Parkinsonian Syndrome tremors from non- Parkinsonian tremor: non- Parkinsonian patients would have more ALTROPANE- binding visible in the SPECT image, while Parkinsonian patients would have less.

There are several conditions that are considered Parkinsonian Syndromes. Parkinson's Disease is the most common form of Parkinsonian Syndrome. Other less common Parkinsonian Syndromes include Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), and drug-induced Parkinsonism.

About Alseres

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's focus is reflected in several important initiatives. CETHRIN, a recombinant- protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of r
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Baptist Health Lexington is ... to receive full Atrial Fibrillation with Electrophysiology Services (EPS) ... Atrial fibrillation is the most common cardiac arrhythmia ... some cases can lead to stroke and possible death. More ... have atrial fibrillation and the numbers are rapidly ...
(Date:12/19/2014)... China separating membrane market has witnessed robust development ... years, albeit as a later starter. In 2012, the size ... approximated RMB12 billion, with the proportion worldwide soaring to 16.3%. ... membrane market will continue its growth rate by around 20% ... will jump to roughly RMB25 billion. An integrated ...
(Date:12/17/2014)... NASHVILLE, Tenn. , Dec. 17, 2014  Strategic ... health management software solutions, today announced a strategic agreement ... the New Jersey regional marketplace.  ... and enhance the health and wellness solutions QualCare brings ... and the surrounding region. QualCare ...
Breaking Medicine Technology:Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3
... Cyberonics, Inc. (Nasdaq: CYBX ) today announced that ... October 29, 2010 of its fiscal year ending April 29, 2011 ... will conduct a conference call to discuss those results on the ... Year 2011 Second Quarter Results Conference Call InstructionsTo listen to the ...
... 2010 Benchmark Electronics, Inc. (NYSE: ... (EMS) provider, announced its Thailand facility has successfully ... audit from the Food and Drug Administration (FDA), ... to manufacture Class III finished devices on behalf ...
Cached Medicine Technology:Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results 2
(Date:12/21/2014)... CannabisClassifieds.com celebrates marijuana’s new legal place at ... of its kind, the site has provided its faithful users ... years running. It uniquely combines the benefits of platforms ... available to the masses. Assuring the potent herb’s followers ... of public approval. , Shane Chattin, Owner of ...
(Date:12/20/2014)... BambooIndustry.com is a leading ... has announced its bamboo flooring promotion for the ... from certified suppliers, and offers the best bamboo ... the current promotion, all customers can enjoy a ... say they know BambooIndustry.com from press releases. , ...
(Date:12/20/2014)... Dress company LunaDress has recently announced its 2015 collection ... big discounts on all of its special occasion dresses & ... a perfect wedding gown. If you have no idea of ... LunaDress. Many different wedding dress styles and our dress experts ... enjoy the current special offer, up to 80% off," the ...
(Date:12/20/2014)... Recently, VogueQueen.com, a leading wedding dress wholesaler ... Online for 2015. Great discounts are now offered ... consumers can get a discount, up to 80% off, ... before January 30, 2015. , VogueQueen.com has recently released ... prom dress promotion. Many customers worldwide like VogueQueen’s special ...
(Date:12/20/2014)... 2014 Atore, Inc, (San Francisco, CA ... first birthday focused portal on December 17th, 2014. ... in both US and Japan. , MERRY BIRTHDAY SITE ... http://merrybirthday.net/message/ , MERRY BIRTHDAY MESSAGE is part of ... world. , Features, Choose from thousands of stock photos ...
Breaking Medicine News(10 mins):Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Atore, Inc. Releasing the First Birthday Portal 2
... At the first sign of a disease pandemic, public ... of the outbreak and the steps that can be ... the recommendation of two mathematical biologists who have modified ... account for the impact of news media coverage. ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, ... reduce the risk of colorectal cancer, new research finds. ... risk of colon cancer. But this study is among the ... risk of side effects such as gastrointestinal bleeding -- may ...
... can divide is dictated by telomeres, stretches of DNA at ... chromosomes and by extension, our genomes intact is ... both aging and cancer. Now, scientists at The Wistar Institute ... function of a crucial domain in the protein known as ...
... Chronic stress acts as a sort of fertilizer ... spread of disease in animal models, researchers at ... discovered that stress is biologically reprogramming the immune ... transforming them instead from soldiers protecting the body ...
... women,s health began about 20 years ago, when it became ... male subjects, were often misinterpreted or misapplied in the cases ... made in lessening the burden of disease and reducing deaths ... and Pitfalls, new from the Institute of Medicine, offers a ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... Wednesday over whether the diet drug Meridia should be pulled ... risk of heart attack and stroke. Members of an ... said the drug should remain available to consumers called for ...
Cached Medicine News:Health News:Disease transmission model says media coverage cuts infection rate and pandemic extent 2Health News:Disease transmission model says media coverage cuts infection rate and pandemic extent 3Health News:Low-Dose Aspirin May Reduce Colon Cancer Risk 2Health News:Low-Dose Aspirin May Reduce Colon Cancer Risk 3Health News:Protein clamps tight to telomeres to help prevent aging ... and support cancer 2Health News:Protein clamps tight to telomeres to help prevent aging ... and support cancer 3Health News:Stress accelerates breast cancer progression in mice 2Health News:Stress accelerates breast cancer progression in mice 3Health News:Stress accelerates breast cancer progression in mice 4Health News:FDA Advisers Divided on Whether to Ban Diet Drug Meridia 2Health News:FDA Advisers Divided on Whether to Ban Diet Drug Meridia 3
Body Suit w/Bra above knee...
Gynecomastia Vest...
Male Compression Vest, Front Closure...
Female Mini-VEST, Front Closure, X-Firm...
Medicine Products: